SCHEMBL7238741

SCHEMBL7238741

CC(C)(C)c1cc2nnn(-c3cc(F)ccc3F)c2[nH]c1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TNKS O95271 2/20 0.34
PARP1 P09874 2/20 0.34
TNKS2 Q9H2K2 2/20 0.34
RXRA P19793 2/20 0.34
GRIN1 Q05586 2/20 0.34
GRIN2B Q13224 2/20 0.34
TP53 P04637 2/20 0.34
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
TUBA3E Q6PEY2 1/20 0.33
TUBA1A Q71U36 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7238892 0.86 HCAR1 (0.40) HCAR1MAPT
SCHEMBL7654621 0.82 HCAR1 (0.43) HCAR1PARP1RXRAGRIN1GRIN2B
SCHEMBL7239019 0.80 HCAR1 (0.33) HCAR1TNKSPARP1TNKS2
SCHEMBL2662168 0.76 ROCK2 (0.34) HCAR1TNKSTNKS2NR1I2MAPT
SCHEMBL2657831 0.76 MEN1 (0.45) L3MBTL1PARP1NPC1
SCHEMBL20267715 0.64 L3MBTL1 (0.41) HCAR1L3MBTL1TP53MAPK14GLA
SCHEMBL30537048 0.64 L3MBTL1 (0.41) HCAR1L3MBTL1TP53MAPK14GLA
SCHEMBL2659107 0.62 TP53 (0.36) L3MBTL1RXRAGRIN1GRIN2BTP53
SCHEMBL2658794 0.62 HCAR1 (0.36) HCAR1PARP1MAPK14NPC1RAB9A
SCHEMBL11845260 0.62 PDE4B (0.41) L3MBTL1TP53TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073717-A1 Triazolo-pyridine derivatives as ligands for GABA receptors MERCK & CO., INC. 2003-04-17 US disclosed
US-6479506-B1 USEFUL IN THE THERAPY OF DELETERIOUS MENTAL STATES SUCH AS ANXIETY MERCK SHARP & DOHME LTD. (GB) 2002-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073717-A1 Triazolo-pyridine derivatives as ligands for GABA receptors GABRA3, GABRA4, GABRA5 HCAR1 240/4885L3MBTL1 1532/4885TNKS 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.